214 related articles for article (PubMed ID: 21343149)
21. Development of oseltamivir and zanamivir resistance in influenza A(H1N1)pdm09 virus, Denmark, 2014.
Trebbien R; Pedersen SS; Vorborg K; Franck KT; Fischer TK
Euro Surveill; 2017 Jan; 22(3):. PubMed ID: 28128091
[TBL] [Abstract][Full Text] [Related]
22. [Clinical characteristics and molecular epidemiology of the novel influenza A (H1N1) infection in children in Shanghai].
Wang XS; Cai JH; Yao WL; Ge YL; Zhu QR; Zeng M
Zhonghua Er Ke Za Zhi; 2013 May; 51(5):356-61. PubMed ID: 23941842
[TBL] [Abstract][Full Text] [Related]
23. Characterization of oseltamivir-resistant influenza A(H1N1)pdm09 viruses in Taiwan in 2009-2011.
Yang JR; Huang YP; Chang FY; Hsu LC; Huang HY; Pan YT; Lin YC; Wu HS; Liu MT
J Med Virol; 2013 Mar; 85(3):379-87. PubMed ID: 23280715
[TBL] [Abstract][Full Text] [Related]
24. Update on oseltamivir-resistant pandemic A (H1N1) 2009 influenza virus: January 2010.
Wkly Epidemiol Rec; 2009 Feb; 85(6):37-40. PubMed ID: 20151493
[No Abstract] [Full Text] [Related]
25. Emerging oseltamivir resistance in seasonal and pandemic influenza A/H1N1.
Renaud C; Kuypers J; Englund JA
J Clin Virol; 2011 Oct; 52(2):70-8. PubMed ID: 21684202
[TBL] [Abstract][Full Text] [Related]
26. Frequency of oseltamivir resistance in Sydney, during the Newcastle outbreak of community transmitted oseltamivir-resistant influenza A(H1N1)pdm09 virus, Australia, June to August 2011.
Wang B; Taylor J; Ratnamohan M; McPhie K; Kesson A; Dixit R; Booy R; Hurt A; Saksena N; Dwyer DE
Euro Surveill; 2012 Jul; 17(27):. PubMed ID: 22790606
[TBL] [Abstract][Full Text] [Related]
27. Impact of mutations at residue I223 of the neuraminidase protein on the resistance profile, replication level, and virulence of the 2009 pandemic influenza virus.
Pizzorno A; Abed Y; Bouhy X; Beaulieu E; Mallett C; Russell R; Boivin G
Antimicrob Agents Chemother; 2012 Mar; 56(3):1208-14. PubMed ID: 22203589
[TBL] [Abstract][Full Text] [Related]
28. Monitoring and characterization of oseltamivir-resistant pandemic (H1N1) 2009 virus, Japan, 2009-2010.
Ujike M; Ejima M; Anraku A; Shimabukuro K; Obuchi M; Kishida N; Hong X; Takashita E; Fujisaki S; Yamashita K; Horikawa H; Kato Y; Oguchi A; Fujita N; Tashiro M; Odagiri T;
Emerg Infect Dis; 2011 Mar; 17(3):470-9. PubMed ID: 21392439
[TBL] [Abstract][Full Text] [Related]
29. Molecular pathway of influenza pan-neuraminidase inhibitor resistance in an immunocompromised patient.
Abed Y; Schibler M; Checkmahomed L; Carbonneau J; Venable MC; Fage C; Giannotti F; Goncalves AR; Kaiser L; Boivin G
Antivir Ther; 2019; 24(8):581-587. PubMed ID: 32031540
[TBL] [Abstract][Full Text] [Related]
30. Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections.
Wang B; Dwyer DE; Blyth CC; Soedjono M; Shi H; Kesson A; Ratnamohan M; McPhie K; Cunningham AL; Saksena NK
Antiviral Res; 2010 Jul; 87(1):16-21. PubMed ID: 20385168
[TBL] [Abstract][Full Text] [Related]
31. Evidence of person-to-person transmission of oseltamivir-resistant pandemic influenza A(H1N1) 2009 virus in a hematology unit.
Moore C; Galiano M; Lackenby A; Abdelrahman T; Barnes R; Evans MR; Fegan C; Froude S; Hastings M; Knapper S; Litt E; Price N; Salmon R; Temple M; Davies E
J Infect Dis; 2011 Jan; 203(1):18-24. PubMed ID: 21148492
[TBL] [Abstract][Full Text] [Related]
32. Delayed emergence of oseltamivir-resistant seasonal influenza A (H1N1) and pandemic influenza A(H1N1)pdm09 viruses in Myanmar.
Dapat C; Saito R; Kyaw Y; Myint YY; Oo HN; Oo KY; Naito M; Hasegawa G; Dapat IC; Suzuki H
Influenza Other Respir Viruses; 2013 Sep; 7(5):766-71. PubMed ID: 23122276
[TBL] [Abstract][Full Text] [Related]
33. Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season.
Baranovich T; Saito R; Suzuki Y; Zaraket H; Dapat C; Caperig-Dapat I; Oguma T; Shabana II; Saito T; Suzuki H;
J Clin Virol; 2010 Jan; 47(1):23-8. PubMed ID: 19962344
[TBL] [Abstract][Full Text] [Related]
34. Comparable fitness and transmissibility between oseltamivir-resistant pandemic 2009 and seasonal H1N1 influenza viruses with the H275Y neuraminidase mutation.
Wong DD; Choy KT; Chan RW; Sia SF; Chiu HP; Cheung PP; Chan MC; Peiris JS; Yen HL
J Virol; 2012 Oct; 86(19):10558-70. PubMed ID: 22811535
[TBL] [Abstract][Full Text] [Related]
35. Genetic diversity and antiviral drug resistance of pandemic H1N1 2009 in Lebanon.
Zaraket H; Kondo H; Tabet C; Hanna-Wakim R; Suzuki Y; Dbaibo GS; Saito R; Suzuki H
J Clin Virol; 2011 Jul; 51(3):170-4. PubMed ID: 21565547
[TBL] [Abstract][Full Text] [Related]
36. Characterization of oseltamivir-resistant influenza virus populations in immunosuppressed patients using digital-droplet PCR: Comparison with qPCR and next generation sequencing analysis.
Pichon M; Gaymard A; Josset L; Valette M; Millat G; Lina B; Escuret V
Antiviral Res; 2017 Sep; 145():160-167. PubMed ID: 28780426
[TBL] [Abstract][Full Text] [Related]
37. Epidemic of influenza A(H1N1)pdm09 analyzed by full genome sequences and the first case of oseltamivir-resistant strain in Myanmar 2017.
Kyaw Win SM; Saito R; Win NC; Lasham DJ; Kyaw Y; Lin N; Thein KN; Chon I; Odagiri T; Thein W; Kyaw LL; Tin OS; Saitoh A; Tamura T; Hirokawa C; Uchida Y; Saito T; Watanabe S; Odagiri T; Kamata K; Osada H; Dapat C; Watanabe H; Tin HH
PLoS One; 2020; 15(3):e0229601. PubMed ID: 32130243
[TBL] [Abstract][Full Text] [Related]
38. Genetic makeup of amantadine-resistant and oseltamivir-resistant human influenza A/H1N1 viruses.
Zaraket H; Saito R; Suzuki Y; Baranovich T; Dapat C; Caperig-Dapat I; Suzuki H
J Clin Microbiol; 2010 Apr; 48(4):1085-92. PubMed ID: 20129961
[TBL] [Abstract][Full Text] [Related]
39. Genetic characterization of circulating seasonal Influenza A viruses (2005-2009) revealed introduction of oseltamivir resistant H1N1 strains during 2009 in eastern India.
Agrawal AS; Sarkar M; Ghosh S; Roy T; Chakrabarti S; Lal R; Mishra AC; Chadha MS; Chawla-Sarkar M
Infect Genet Evol; 2010 Dec; 10(8):1188-98. PubMed ID: 20678590
[TBL] [Abstract][Full Text] [Related]
40. A two-year survey of the oseltamivir-resistant influenza A(H1N1) virus in Yamagata, Japan and the clinical effectiveness of oseltamivir and zanamivir.
Matsuzaki Y; Mizuta K; Aoki Y; Suto A; Abiko C; Sanjoh K; Sugawara K; Takashita E; Itagaki T; Katsushima Y; Ujike M; Obuchi M; Odagiri T; Tashiro M
Virol J; 2010 Mar; 7():53. PubMed ID: 20202225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
